Amphastar Pharmaceuticals, Inc.
AMPHAmphastar Pharmaceuticals is a publicly traded American speciality pharmaceutical company. It was incorporated in May 2004 and primarily develops, manufactures, and sells inhalation and intranasal products.
Drugs in Pipeline
13
Phase 3 Programs
5
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 1 past
No catalysts found.
Epinephrine inhalation aerosol
Asthma
I004
Pharmacokinetics
E004 (Epinephrine Inhalation Aerosol) HFA-MDI
Asthma
Epinephrine HFA-MDI (E004)
Asthma
Primatene Mist
Asthma
Hyaluronidase
Allergic Skin Reaction
Proventil® MDI
Asthma
A006
Asthma
Arm T1: Primatene Mist HFA
Asthma
albuterol inhalation powder
Asthma
Albuterol DPI 25 mcg/inh
Asthma
A006 DPI
Asthma
Epinephrine Inhalation Aerosol, HFA
Asthma
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Epinephrine inhalation aerosol | Phase 3 | Asthma | - | - |
I004 | Phase 3 | Pharmacokinetics | - | - |
E004 (Epinephrine Inhalation Aerosol) HFA-MDI | Phase 3 | Asthma | - | - |
Epinephrine HFA-MDI (E004) | Phase 3 | Asthma | - | - |
Primatene Mist | Phase 3 | Asthma | - | - |
Hyaluronidase | Phase 2 | Allergic Skin Reaction | - | - |
Proventil® MDI | Phase 2 | Asthma | - | - |
A006 | Phase 2 | Asthma | - | - |
Arm T1: Primatene Mist HFA | Phase 2 | Asthma | - | - |
albuterol inhalation powder | Phase 2 | Asthma | - | - |
Albuterol DPI 25 mcg/inh | Phase 2 | Asthma | - | - |
A006 DPI | Phase 2 | Asthma | - | - |
Epinephrine Inhalation Aerosol, HFA | Phase 2 | Asthma | - | - |